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Among three recognised clinical phenotypes, type 3a Gaucher’s disease is characterised by mild to severe systemic disease,
neurological manifestations and myoclonic seizures. We report the long term clinical and electrophysiological follow-up of a
27-year old man with a diagnosis of type 3a Gaucher’s disease, which was confirmed by bone marrow biopsy examination and
leukocyte glucocerebrosidase level measurement. His neurological examination was normal throughout the follow-up period.
EEG examination, recorded five days after the first seizure, revealed generalised nonrhythmic paroxysmal rapid spikes with
occipital predominance increased by photic stimulation and normal background activity. The frequency of seizures increased
from 3–4/year to 1–2/month within a follow-up period of 12 years and a repeat EEG examination on the eight year of diagnosis
revealed additional background slowing. A giant potential was obtained in somatosensory evoked potential (SEP) examination.
EEG findings of this case demonstrate a specific pattern with rapid spike activity, photosensitivity, eye closure sensitivity and
gradual background slowing.
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INTRODUCTION
Gaucher’s disease is an autosomal recessive disorder
caused by deficiency of glucocerebrosidase and is the
most prevalent lysosomal storage disorder. According
to a widely accepted classification clinical findings are
divided into three groups.
The third type, also called the juvenile form, repre-
sents a more heterogeneous clinical status and patients
may present with varying degrees of neurological and
systemic manifestations. This type has therefore been
divided into two subgroups (3a and 3b). In type 3a,
patients exhibit a clinical picture which may be identi-
cal to progressive myoclonic epilepsy, with or without
horizontal supranuclear gaze palsy, and mild systemic
findings. We report the peculiar clinical and electroen-
cephalographic (EEG) findings, in a case of type 3a
Gaucher’s disease, followed for 12 years.
CASE REPORT
A 27-year old man was healthy until 14 years of age,
when he was discovered to have an enlarged liver dur-
ing physical examination performed for symptoms of
stomach ache, nausea and loss of appetite. He was di-
agnosed as having Gaucher’s disease by bone marrow
biopsy. Serum acid phosphatase level, biochemistry
and blood count profiles were all normal throughout
his follow-up period.
The patient began to have generalised seizures dur-
ing sleep at the age of 15. All EEG recordings were
obtained with the 10–20 standard electrode place-
ment and included awake-alert record, photic stim-
ulation, hyperventilation activation. EEG examina-
tion recorded five days after the first seizure (1986)
revealed generalised nonrhythmic paroxysmal rapid
spikes (6–8 Hz) with marked occipital predomi-
nance increased by photic stimulation and normal
background activity (Fig. 1). Similar findings were
recorded in the second EEG examination (1986) af-
ter a six months seizure free period and stable clinical
status (Fig. 2). The frequency of spikes increased in
harmony with the frequency of flicker (up to 30 Hz)
and spikes frequently occurred on eye closure (Figs 1
and 2). Hyperventilation, also, seemed to create a
slight augmentation in the frequency but the effect of
photic stimulation was much more prominent. He con-
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Fig. 1: Generalised nonrhythmic paroxysmal rapid spikes and normal background activity are observed in the first EEG examina-
tion of the patient. There is marked eye closure sensitivity. Eye closure is indicated by the letters EC. The frequency of the flicker
is 15 Hz.
tinued to have rare seizures (3–4/year) and there was
no marked difference in any of his seven consecutive
EEG examinations performed at changing intervals. A
repeat EEG examination on the eighth year of diag-
nosis (1994) revealed additional background slowing,
which persisted in all of his following control record-
ings (Fig. 3). The frequency of seizures increased in
the eleventh year of follow-up after a seizure free pe-
riod of two years without any known predisposing fac-
tor and he began to have one or two seizures per month
despite triple antiepileptic therapy with adequate doses
and blood levels. All of the convulsions were of a noc-
turnal generalised tonic clonic type and there was no
reported myoclonus.
He was hospitalised in February 1998 and April
1998 because of increased frequency of seizures (5–
7 per month) and status epilepticus respectively. Day-
time seizures began to appear at this time. Neurolog-
ical examination was unremarkable except for a bor-
derline mental status with an intelligence quotient of
82. The patient and his family denied any apparent
intellectual decline noticeable in his daily life. Visual
Evoked Potential examination (VEP) and cranial MRI
examinations were normal. N20 and P25 wave ampli-
tudes were found to be increased on SEP examination.
Leukocyte glucocerebrosidase level (2.4 mmol/hour
mg protein) was below normal levels.
DISCUSSION
Type 1 Gaucher’s disease (chronic nonneuronopathic
form) may present at any age with serious systemic
manifestations but usually without neurological find-
ings. Type 2 (acute neuronopathic form) patients ex-
hibit an extensive involvement of the central nervous
system together with systemic findings. Those patients
that can not be included in the above categories are
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Fig. 2: The frequency of spikes changes in harmony with the frequency of flicker. The frequency of the flicker is 5 Hz.
Fig. 3: Background slowing which was observed on the eighth year of diagnosis persists in all of the patient’s following EEG
recordings.
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classified as having type 3 (subacute neuronopathic
form) Gaucher’s disease1–3.
This third type, also called the juvenile form,
represents a more heterogeneous clinical status and
patients may present with varying degrees of neuro-
logical and systemic manifestations4–6. This type has
therefore been divided into two subgroups (3a and 3b).
In type 3a, patients exhibit a clinical picture, which
may be identical to progressive myoclonic epilepsy
with or without horizontal supranuclear gaze palsy and
mild systemic findings. The findings in our case fit
this type with very mild systemic disease, epilepsy and
EEG abnormalities. However, he has no myoclonic ac-
tivity except in the eyelids.
There are few reports on the EEG findings of
Gaucher’s disease. Listed abnormalities in type 3 are
background slowing with generalised epileptiform dis-
charges, marked photosensitivity and multiple spike
bursts prominent over the posterior regions7–9. EEG
findings in our case demonstrate a similar pattern
with rapid spike activity, photosensitivity in harmony
with the flicker frequency, gradual background slow-
ing. These findings seem to be specific for this type
of disease. Another interesting finding in our case is
eye closure sensitivity, which has not been described
previously in other Gaucher’s disease patients. This
case is of particular importance in having significant
and abundant abnormal EEG findings even in the ear-
liest stages of disease, despite lack of severe neuro-
logical involvement. The patient currently continues
to lead his life without any problems and his somatic
and mental neurological status does not seem to be
grossly affected. The photoconvulsive response is one
of the hallmarks of the EEG findings in this patho-
logical condition and has been previously assumed to
be associated with the involvement of thalamocortical
projections and the reticular activating system. This
phenomenon may therefore be consistent with early
involvement of these pathways together with the rela-
tive sparing of other central nervous system structures,
especially cortical layers. This presumption warrants
further pathological and electrophysiological assess-
ment.
Nevertheless, seizure frequency seems to be a poor
indicator of the clinical status of Gaucher’s disease, as
revealed in our case by severe EEG findings recorded
after a seizure free period of six months and physicians
should be alert for the presence of a serious cerebral
disease, despite lack of frequent seizures.
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